# Expression Patterns of LALBA and Nucleolin and Their Clinical, Prognostic, and Immune Relevance in Breast Cancer Tissues of Mexican Patients

**Authors:** Mariana Navarro-Real, Juan Omar Zavala-López, Juliana Marisol Godínez-Rubí, Antonio Quintero-Ramos, Alicia Del Toro-Arreola, Ramon Franco-Topete, Ángel Quiroz Bolaños, Antonio Topete, Adrián Daneri-Navarro

PMC · DOI: 10.3390/ijms27031561 · International Journal of Molecular Sciences · 2026-02-05

## TL;DR

This study explores the expression of LALBA and NCL in breast cancer tissues from Mexican patients and their links to tumor aggressiveness, immune response, and survival.

## Contribution

The study identifies LALBA and NCL as potential biomarkers with clinical and immune relevance in breast cancer.

## Key findings

- LALBA overexpression is linked to aggressive breast cancer subtypes and a trend toward poorer survival.
- NCL expression correlates with improved survival and increased immune cell infiltration.
- Both proteins show associations with immune markers like PD-L1 and TILs.

## Abstract

Breast cancer is the most common and deadliest cancer among women. While overexpression of specific markers guides disease stratification and has enabled the development of targeted therapies, identifying new therapeutic targets remains critical, particularly for aggressive subtypes lacking effective treatments. This study evaluated the expression of α-Lactalbumin (LALBA) and nucleolin (NCL) in breast cancer tissues from Mexican patients using gene expression analysis and immunohistochemistry. LALBA, a major milk protein normally expressed only during late pregnancy and lactation, was detected in nearly all tumor samples and showed higher levels in aggressive subtypes, with overexpression displaying a slight trend toward poorer overall survival. NCL, a multifunctional nucleolar protein, exhibited predominantly nuclear localization, with moderate expression associated with improved survival. Both proteins correlated with tumor immune features, including increased tumor-infiltrating lymphocytes (TILs) and PD-L1 expression for LALBA, and elevated CD8+ T cells, PD-L1, and TIM-3 expression for NCL. Overall, these findings suggest that LALBA and NCL are associated with tumor aggressiveness, immune context, and survival trends in breast cancer. Additional studies in larger cohorts are needed to define their clinical relevance.

## Linked entities

- **Genes:** LALBA (lactalbumin alpha) [NCBI Gene 3906], NUCLEOLIN (nucleolin multifunctional protein) [NCBI Gene 4691]
- **Proteins:** NUCLEOLIN (nucleolin multifunctional protein)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** LALBA (lactalbumin alpha) [NCBI Gene 3906] {aka HAMLET, LYZG}, NUCLEOLIN (nucleolin multifunctional protein) [NCBI Gene 4691] {aka C23, NCL, Nsr1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868] {aka CD366, HAVcr-2, KIM-3, SPTCL, TIM3, TIMD-3}
- **Diseases:** Breast Cancer (MESH:D001943), cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898300/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898300/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898300/full.md

---
Source: https://tomesphere.com/paper/PMC12898300